https://pressroom.prlog.org/ScionxBio/ About ScionxBio - ScionxBio, formerly Eleven Therapeutics, is a Cambridge-based preclinical biotechnology company developing long-acting, programmable xRNA therapeutics for cardio-metabolic disease. https://www.prlog.org/13155709-scionxbio-is-launched-from-eleven-therapeutics-appoints-dr-adi-gilboa-geffen-as-ceo.html The rebrand follows a strategic horizontal split; ScionxBio focuses the xRNA modality exclusively on long-acting therapeutics for cardio-metabolic disease under new CEO Dr. Adi Gilboa-GeffenWed, 01 Jul 2026 14:37:36 GMT